Clinical trial
Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced…
NCT00002974 · University of Wisconsin, Madison, Other · Completed
Key facts
| NCT number | NCT00002974 |
|---|---|
| Title | Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma |
| Official title | A Phase II Study of Whole Blood Hyperthermia and Ice Chemotherapy in Sarcoma Patients |
| Lead sponsor | University of Wisconsin, Madison, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sarcoma |
| Intervention type | Drug, Procedure |
| Interventions | carboplatin, etoposide, ifosfamide, hyperthermia treatment |
| Enrollment | 34 |
| Start date | Jul 1, 1996 |
| Primary completion | Jul 1, 2001 |
| Completion | Apr 1, 2003 |
| First posted | Mar 30, 2004 |
| Last update posted | Dec 13, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: